MedPath

Busulfan

These highlights do not include all the information needed to use BUSULFAN safely and effectively. See full prescribing information for BUSULFAN.BUSULFAN for injection, for intravenous useInitial U.S. Approval: 1999

Approved
Approval ID

8789b88c-ce41-477e-9194-31ae752dece0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 7, 2023

Manufacturers
FDA

Nexus Pharmaceuticals LLC

DUNS: 620714787

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Busulfan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code14789-013
Application NumberANDA207794
Product Classification
M
Marketing Category
C73584
G
Generic Name
Busulfan
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 7, 2023
FDA Product Classification

INGREDIENTS (3)

BusulfanActive
Quantity: 60 mg in 10 mL
Code: G1LN9045DK
Classification: ACTIB
N,N-dimethylacetamideInactive
Code: JCV5VDB3HY
Classification: IACT
Polyethylene Glycol 400Inactive
Code: B697894SGQ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Busulfan - FDA Drug Approval Details